Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

CAM 101

Next Previous
Search
Drug Profile

CAM 101

Alternative Names: Aurarix; CAM 101; Elate Ocular; FD hPL; fibrinogen-depleted human platelet lysate - Cambium Bio

Latest Information Update: 14 Jul 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Emory University
  • Developer Cambium Bio
  • Class Cell therapies
  • Mechanism of Action Cell replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I/II Dry eyes

Most Recent Events

  • 05 Apr 2024 Cambium Medical Technologies plans a phase III trial for Dry eyes in mid-2025
  • 16 Jan 2024 Cambium Medical Technologies holds a Type B meeting with the US FDA regarding the potency assay, implementation of a pathogen-inactivation step in the manufacturing process, and requirements for a comparability study
  • 23 Feb 2022 CAM 101 is still in phase I/II trials for Dry eyes in USA (Cambium Medical Technologies website, February 2022)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top